ArticleOncology letters2013

PRKACB is downregulated in non-small cell lung cancer and exogenous PRKACB inhibits proliferation and invasion of LTEP-A2 cells.

Yong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.